COMPANY
Novilytic
NIH awards 9
- NIH award 5R44GM137713-02 FY2021: $738,228 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. The PROTEOMETER; A Continuous Upstream Proce source ↗
- NIH award 1R44GM137713-01 FY2020: $689,740 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. The PROTEOMETER; A Continuous Upstream Proce source ↗
- NIH award 3R44GM116663-03S1 FY2018: $92,761 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. SAMPLE PREPARATION; The Achilles Heel of Ma source ↗
- NIH award 5R44GM116663-03 FY2018: $749,570 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. SAMPLE PREPARATION; The Achilles Heel of Mas source ↗
- NIH award 2R44GM116663-02A1 FY2017: $749,570 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. SAMPLE PREPARATION; The Achilles Heel of M source ↗
- NIH award 1R43GM116663-01 FY2016: $147,170 awarded for that fiscal year; activity R43 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. SAMPLE PREPARATION; The Achilles Heel of Mas source ↗
- NIH award 5R44GM097798-03 FY2015: $480,440 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. A NEW METHOD FOR THE ANALYSIS OF VITAMIN D source ↗
- NIH award 2R44GM097798-02 FY2014: $489,940 awarded for that fiscal year; activity R44 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. A NEW METHOD FOR THE ANALYSIS OF VITAMIN D source ↗
- NIH award 1R43GM097798-01 FY2011: $99,537 awarded for that fiscal year; activity R43 (SBIR); PI REGNIER, FRED E; recipient as written: NOVILYTIC, LLC, West Lafayette, IN. A NEW METHOD FOR THE ANALYSIS OF VITAMIN D source ↗
Funding and NIH signals
- SEC Form D raise Raised $531K (Form D filed Dec 15, 2025). SEC Form D 0001850261-25-000002 (Dec 15, 2025)
Evidence (1 event)
- Dec 15, 2025 · SEC Form D 0001850261-25-000002
Name of Issuer: Novilytic, LLC; CIK: 1850261; Address: West Lafayette, IN; Submission type: D; Filing date: 2025-12-15; Industry Group: Biotechnology; Date of First Sale: 2025-12-01; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 530800; Federal exemptions: 06b
- Dec 15, 2025 · SEC Form D 0001850261-25-000002